Amanote Research

Amanote Research

    RegisterSign In

PCSK9 Inhibition: The Way Forward in the Treatment of Dyslipidemia

BMC Medicine - United Kingdom
doi 10.1186/s12916-015-0503-4
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

October 12, 2015

Authors
Robert M. StoekenbroekJohn JP KasteleinRoeland Huijgen
Publisher

Springer Science and Business Media LLC


Related search

The Way Forward in HCV Treatment — Finding the Right Path

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2008English

The Way Forward in Molecular Electrocatalysis

Inorganic Chemistry
Inorganic ChemistryChemistryTheoretical ChemistryPhysical
2016English

Corruption in Africa: The Way Forward

International Journal of Political Science
2019English

Real World Treatment Patterns of PCSK9 Inhibitors Among Patients With Dyslipidemia in Germany, Spain, and United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

International Psychiatry – The Way Forward

International Psychiatry
2003English

Enzyme Standardization--The Way Forward?

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
1997English

The Three Rs: The Way Forward

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1996English

The Way Forward Is Through Paris

Nature
Multidisciplinary
2015English

Anticancer Drug Development: The Way Forward

Oncologist
Cancer ResearchMedicineOncology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy